STOCK TITAN

John M Evans to sell 25,000 BEAM (NASDAQ: BEAM) shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

John M Evans has filed a notice to sell 25,000 shares of BEAM common stock on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned sale has an aggregate market value of $708,947.50, with 101,474,944 shares outstanding.

The 25,000 shares to be sold were acquired on January 30, 2026 via a stock option exercise from the issuer, paid in cash on the same date. During the past three months, Evans also sold 25,000 common shares on January 29, 2026 for gross proceeds of $734,582.50.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for BEAM by John M Evans show?

The Form 144 shows that John M Evans plans to sell 25,000 BEAM common shares on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $708,947.50, after acquiring the shares through a same-day stock option exercise paid in cash.

How many BEAM shares is John M Evans planning to sell under this Form 144?

John M Evans plans to sell 25,000 shares of BEAM common stock. These shares will be sold on the NASDAQ, with the filing listing an aggregate market value of $708,947.50 and Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction.

How and when did John M Evans acquire the BEAM shares he plans to sell?

The 25,000 BEAM common shares were acquired on January 30, 2026 through a stock option exercise from the issuer. The filing states that payment for these shares was made in cash on the same date, directly linking acquisition and payment to the planned sale.

What prior BEAM share sales by John M Evans are disclosed in the last three months?

The filing discloses that John M Evans sold 25,000 BEAM common shares on January 29, 2026. These shares generated gross proceeds of $734,582.50, and this transaction is reported as part of the required three-month sale history for the person filing the notice.

Which broker and exchange are involved in John M Evans’s planned BEAM share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The Form 144 lists the NASDAQ as the securities exchange where the 25,000 BEAM common shares will be sold.

How many BEAM shares are outstanding according to this Form 144 filing?

The Form 144 states that 101,474,944 BEAM common shares are outstanding. This figure provides context for the planned 25,000-share sale by John M Evans but is listed separately from the transaction details and market value amounts in the filing’s securities information section.
Beam Therapeutics Inc.

NASDAQ:BEAM

BEAM Rankings

BEAM Latest News

BEAM Latest SEC Filings

BEAM Stock Data

2.97B
100.22M
1.19%
105.17%
25.19%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE